69 publications

Name Date Type Actions

2010 Activity Report

P_06 VÉTOQUINOL’S PROUD HISTORY
<br>
P_12 SPOTLIGHT ON INNOVATION
<br>
P_18 AN ONGOING DAILY COMMITMENT
TO VETERINARIANS
<br>
P_24 AN INTERNATIONAL COMPANY
MAINTAINING A LOCAL PRESENCE
IN GLOBAL MARKETS
<br>
P_28 GOVERNANCE AND KEY FIGURES

 		27/04/2011 Annual Report

2010 annual earnings

Lure (France), April 4, 2011 – Vétoquinol’s Board of Directors, meeting on March 18, 2011, has reviewed the Group’s business and approved its 2010 financial statements.

 		04/04/2011 Public releases

2010 annual earnings Vétoquinol

Contents :
<br>> Highlights
<br>> 2010 Consolidated
Financial Statements
<br>> Strategy and Outlook
<br>> Questions and Answers

 		12/04/2011 Annual Report

2010 Revenues grow 11.8%, driven by organic growth

The Vétoquinol Group reports sustained sales growth driven by its “hybrid” business model, supported by a sound level of organic growth.

 		25/01/2011 Public releases

2011 Half Year Results

2011 Half year results

 		31/08/2011 Half Year Report

2023 ANNUAL RESULTS

Annual sales: €529m (stable at constant exchange rates)
Essentials sales: €313m (+4.5% at constant exchange rates)
Net income - Group share: €56m (10.5% of sales)
EBITDA: €113m (21.3% of sales)
Free cash-flow: €89m

 		20/03/2024 Public releases

2024 Calendar of financial communication

Vetoquinol published its calendar of financial communication for 2024.

 		03/01/2024 Agenda

ANNUAL RESULTS 2023 (slideshow)

01.2023 Highlights
02.2023 Consolidated financial statements
03.Strategy and outlook

 		20/03/2024 Annual Report

Annual sales 2023: €529 million

Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates)

 		24/01/2024 Public releases

Arrêté de la feuille de présence (french)

 		30/06/2011 Shareholders´s Meeting